Healthcare startup Suki raises $70 million to build AI assistants for hospitals
Adds detail on customers in paragraph 6
Update with details on healthcare partnership in paragraph 6
By Krystal Hu
Oct 10 (Reuters) - Suki, a startup that offers to build artificial intelligence (AI) assistants in healthcare, has raised $70 million in a Series D round, the company told Reuters, as investors place bets on the adoption of generative AI-powered applications in the sector.
The funding round was led by London-based tech investment firm Hedosophia, with additional investments from Venrock and March Capital. This brings Suki's total funding to $165 million.
Redwood City, California-based Suki did not disclose its valuation, but a person familiar to the funding round said the latest proceeds valued the company at about $500 million.
Founded in 2017 by former Google and Flipkart executive Punit Soni, Suki develops AI voice assistant to reduce the administrative workload for healthcare providers. Its primary products Suki Assistant and Suki Platform have seen increased adoption since the boom of OpenAI's ChatGPT, as healthcare systems across the country explore how the technology can better aid doctors' clinical work.
"When the AI trend kicked in, every health system wanted to have an AI strategy," Soni said, adding that the company has built proprietary tech stack by being in the space early.
The company capitalized on the demand, saying it now has established partnerships with over 300 health systems such as St. Mary's Healthcare in New York. Suki also touts the broadest integration of Electronic Health Record systems (EHRs), working with Epic, Oracle-owned Cerner, Athena, as well as MEDITECH.
Soni said the latest funding will be used to accelerate product development, adding more features to the assistant and build tools to manage the use of multiples AI models.
Suki competes with Microsoft-owned Nuance, whose Dragon Medical One is widely used for its speech recognition and clinical documentation, as well as other startups such as Abridge, which has raised $150 million from VC investors to train medical AI models.
Reporting by Krystal Hu in New York; Editing by Sherry Jacob-Phillips and Nick Zieminski
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
